The Roche Group, including Genentech and Chugai, has brought many highly effective drugs onto the market and is a world leader in innovative cancer drugs. Other areas include viral infections, metabolic, central nervous system disorders and inflammatory diseases.
As the world leader in in-vitro diagnostics, Roche supplies a wide range of rapid, reliable instruments and tests for disease screening and diagnosis in labratories, at the point of care, and for patient self-management.
At Roche, our primary objective is to provide healthcare solutions that deliver superior options for diagnosis and treatment to clinicians and patients. As one of the world's leading healthcare companies with combined strengths in pharmaceuticals and diagnostics, no company is better suited for this task.
Roche's personalized healthcare approach uses new molecular insights and molecular diagnostic tests to better tailor medicines and better manage diseases.